Qiagen N V (QGEN) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Qiagen N v   (NYSE: QGEN)


Qiagen N V 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Qiagen N V 's ROA in the fourth quarter of 2025?
Qiagen N v achieved a return on average assets (ROA) of 6.76 % in its fourth quarter of 2025, this is above QGEN's average return on assets of 3.56%.
Qiagen N V s assets during the 12 months ending in the fourth quarter of 2025 are valued at $6 billion

ROA has improved compared to 1.38% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector 148 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 1066.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change 16.4 % 10.4 % 10.4 % 10.4 % 10.52 %
Y / Y Net Income Change 408.28 % - - - -75.51 %
Net Income (TTM) in million 425 84 84 84 84
Return On Assets (TTM) 6.76 % 1.38 % 1.41 % 1.45 % 1.49 %
QGEN's Total Ranking # 1066 # # # # 2322
Total Assets (TTM) in million 6,281 6,281 6,281 6,281 5,396
Seq. Total Assets Change 0 % 0 % 0 % 16.4 % -5.15 %
Seq. Net Income Change - - - - -

QGEN's 5 Years Annual ROA >> Back to QGEN Management Effectiveness >> Compare QGEN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 19
Sector # 149
Overall # 1059

Return On Assets Statistics
High Average Low
8.34 %
3.56 %
-0.79 %
(Dec 31 2021)   (Dec 31 2019)





Financial Statements
Qiagen N V 's Assets $ 6,281 million QGEN's Balance sheet
Qiagen N V 's Income $ 425 million Quarterly QGEN's Income Statement
QGEN's Income by Division See QGEN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 5.13 % 18.49 % -9.83 % -0.25 % 8.21 %
Total Assets in million 6,082 5,786 4,883 5,415 5,429
Y / Y Net Income Change 408.28 % -75.51 % -19.35 % -17.44 % 42.71 %
Net Income in million 425 84 341 423 513
Annual Return On Assets 6.99 % 1.44 % 6.99 % 7.82 % 9.44 %

QGEN's 5 Years Annual ROA >> Back to QGEN Management Effectiveness >> Compare QGEN ROA to its Competitors



Comment on QGEN's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 6.99 % compared to prior year, due to annual net income growth of 408.28 % to $424.88 million, while value of Qiagen N V 's overall assets grew just by 5.13 % to $6,082.17 million, compared to $6,082.17 a year before.


More Return On Assets Ratios
QGEN's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
QGEN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for QGEN's Competitors
Subscribers only: Roa for Qiagen N V 's Suppliers
Subscribers only: Return On Assets for QGEN's Customers

You may also want to know
QGEN's Roi QGEN's Inventory Turnover Ratio QGEN's Growth Rates QGEN's Dividend Comparisons
QGEN's Profitability Ratios QGEN's Asset Turnover Ratio QGEN's Dividend Growth
QGEN's Roe QGEN's Valuation Ratios QGEN's Financial Strength Ratios QGEN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Resmed Inc   18.44 %
Pro dex Inc   18.07 %
Zoetis Inc   17.92 %
Inspire Medical Systems inc   17.91 %
United Therapeutics Corporation  17.29 %
Krystal Biotech Inc   17.12 %
Electromed Inc   16.83 %
Arrowhead Pharmaceuticals Inc   16.32 %
Vertex Pharmaceuticals Inc  16.23 %
Chemed Corporation  16.06 %
Mimedx Group Inc   15.89 %
Sbc Medical Group Holdings Incorporated  15.69 %
Indivior Pharmaceuticals Inc   15.43 %
Puma Biotechnology Inc   15.36 %
Argenx Se  14.88 %
Gilead Sciences Inc   14.82 %
Merck and Co Inc   14.64 %
Intuitive Surgical Inc   14.53 %
Strata Critical Medical Inc   14.15 %
Halozyme Therapeutics Inc   14.09 %
Black Diamond Therapeutics Inc   13.91 %
Johnson and Johnson  13.76 %
Harmony Biosciences Holdings inc   13.67 %
Illumina Inc   13.55 %
Waters Corporation  13.35 %
Keros Therapeutics Inc   13.27 %
Prestige Consumer Healthcare Inc   13.25 %
Spero Therapeutics Inc   13.04 %
Hca Healthcare Inc   12.98 %
Novartis Ag  12.59 %

Date modified: 2026-07-07T12:43:35+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.